Dong-E-E-Jiao Co.,Ltd.

000423

CNE0000006Y9

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 2024-12-10			5-day change	1st Jan Change
58.11 ^CNY	+1.18%		-0.29%	+17.82%

Nov. 18	Macquarie Starts Dong-E-E-Jiao at Outperform with 70 Yuan Price Target	MT
Nov. 11	Dong-E-E-Jiao Co.,Ltd. Announces Directorate Appointments	CI

Tranche Update on Dong-E-E-Jiao Co.,Ltd.'s Equity Buyback Plan announced on January 2, 2024.

January 24, 2024 at 11:00 am EST

From December 31, 2023 to January 25, 2024, the company has repurchased 1,512,400 shares, representing 0.23% for CNY 75.87 million. With this, the company has completed the repurchase of 1,512,400 shares, representing 0.23% for CNY 75.87 million under the buyback announced on January 2, 2024.

Latest news about Dong-E-E-Jiao Co.,Ltd.

Macquarie Starts Dong-E-E-Jiao at Outperform with 70 Yuan Price Target	Nov. 18	MT
Dong-E-E-Jiao Co.,Ltd. Announces Directorate Appointments	Nov. 11	CI
Dong-E-E-Jiao's Q3 Profit Jumps 64%, Operating Income Climbs 25%	Oct. 31	MT
Dong-E-E-Jiao Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2024	Oct. 30	CI
Dong-E-E-Jiao Chairman Steps Down	Oct. 23	MT
Chinese Shares Rise on Stimulus Hopes; Shengtak New Material, Dong-E-E-Jiao, Tech-Bank Food Close With Gains	Oct. 10	MT
Dong-E-E-Jiao Expects Q3 Profit to Rise Up to 73%; Shares Climb 7%	Oct. 10	MT
China Resources Pharmaceutical Group Limited Announces Resignation of Bai Xiaosong as Chief Executive Officer	Aug. 29	CI
Dong-E-E-Jiao Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024	Aug. 16	CI
Dong-E-E-Jiao Co.,Ltd. Announces Board Appointments	Aug. 08	CI
China Renaissance Starts Dong-E-E-Jiao at Buy With 83.78 Yuan Price Target	Jul. 29	MT
Dong-E-E-Jiao Forecasts Up to 43% Rise in H1 Profit	Jul. 12	MT
Dong-E-E-Jiao Plans Sale of 46 Million Yuan Property	Jul. 08	MT
Dong-E-E-Jiao Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 25	CI
Dong-E-E-Jiao Forecasts Up to 55% Jump in Q1 Profit	Apr. 12	MT
Dong-E-E-Jiao's Profit Jumps 47.6% in 2023	Mar. 22	MT
Dong-E-E-Jiao Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 21	CI
Dong-E-E-Jiao Co.,Ltd.'s Equity Buyback announced on January 2, 2024, has closed with 1,512,400 shares, representing 0.23% for CNY 75.87 million.	Jan. 24	CI
Tranche Update on Dong-E-E-Jiao Co.,Ltd.'s Equity Buyback Plan announced on January 2, 2024.	Jan. 24	CI
Dong-E-E-Jiao Co.,Ltd. announces an Equity Buyback for 1,660,000 shares, for CNY 124.2 million.	Jan. 02	CI
Dong-E-E-Jiao Co.,Ltd. authorizes a Buyback Plan.	Dec. 30	CI
Dong-E-E-Jiao's Nine-Moth Profit Rises on Higher Revenue	23-10-31	MT
Dong-E-E-Jiao Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-30	CI
Dong-E-E-Jiao Expects January-September Attributable Profit to Rise Up to 60%	23-10-10	MT
Dong-E-E-Jiao Co.,Ltd. Provides Earnings Guidance for the Nine Months Ended 30 September 2023	23-10-10	CI

Chart Dong-E-E-Jiao Co.,Ltd.

Duration

Period

000423: Dynamic Chart

Company Profile

Dong-E-E-Jiao Co., Ltd. specializes in the manufacturing and marketing of Chinese traditional medicines and health products. The products are primarily for deficiencies in the blood, immunodeficiency, indigestion, insomnia and fatigue.

Employees

3,678

Sector

Pharmaceuticals

Calendar

2025-03-20 - Q4 2024 Earnings Release (Projected)

More about the company